/EINPresswire.com/SMi proudly present their 2012 RNAi & Nanotechnology conference on 11th & 12th June 2012 in London. Featuring presentations on new technologies from senior industry executives from all over the pharmaceutical sector, this event promises to be the perfect forum for networking and problem solving with key opinion leaders in the field.
New for 2012: focus on the utility of nanotechnology to aid the delivery and development of novel therapeutics in the field of RNAi, miRNA and siRNA.
7 Reasons why you should attend:
1.Understand structure-activity relationships of chitosan/siRNA nanoparticles in vitro and in vivo
2.Evaluating targeted exosomes for targeted delivery of oligonucleotides
3.Discuss antisense RNA oligonucelotide delivery by nanoconstructs
4.Exploring translational research by targeting RNA with locked nucleic acids
5.Updates in RNAi and antisense technologies
6.Learn about novel methods for assessing oligonucelotide loading and efficacy
7.Develop you understanding of nanotechnology commercialization strategies
Book before 5th April 2012 and Save £300
Alternatively Contact Fateja Begum on telephone
+44 (0) 20 7827 6184 or email on fbegum@smi-online.co.uk
